- $229.72m
- $159.44m
- $194.06m
LifeMD Inc reports results for the quarter ended December 31 - Earnings Summary
LifeMD rises as 2025 revenue forecast exceeds estimates
Brief: LifeMD Inc Outlook Q1 2025 Total Revenue In The Range Of $61 Million To $63 Million
Brief: LifeMD Q4 Revenue USD 64.3 Million Versus. Ibes Estimate USD 57.4 Million
LifeMD Inc expected to post a loss of 5 cents a share - Earnings Preview
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound (updated)
Teladoc climbs on Lilly tie up to offer Zepbound
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
Hims & Hers shines bright in a testing year for telehealth stocks
U.S. STOCKS ON THE MOVE-Talen Energy, Biogen, Ovintiv
Telehealth firms fall as Amazon offers low-cost telehealth services for Prime members
LifeMD Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Lifemd Launches Testorx, A New Rex MD Direct-To-Consumer Testosterone Replacement Therapy Telehealth Offering
U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings
U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer
Telehealth firms fall after Lilly launches single-dose vials of weight-loss drug
LifeMD Inc reports results for the quarter ended in June - Earnings Summary
LifeMD Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: LifeMD Expects To Begin Accepting Medicare